Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    American Society of Clinical Oncology (ASCO) ; 2008
    In:  Journal of Clinical Oncology Vol. 26, No. 35 ( 2008-12-10), p. 5671-5678
    In: Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 26, No. 35 ( 2008-12-10), p. 5671-5678
    Abstract: To compare prospectively and retrospectively defined benchmarks for the quality of end-of-life care, including a novel indicator for the use of opiate analgesia. Methods Linked claims and cancer registry data from 1994 to 2003 for New Jersey and Pennsylvania were used to examine prospective and retrospective benchmarks for seniors with breast, colorectal, lung, or prostate cancer who participated in state pharmaceutical benefit programs. Results Use of opiates, particularly long-acting opiates, was low in both the prospective and retrospective cohorts (9.1% and 10.1%, respectively), which supported the underuse of palliative care at the end-of-life. Although hospice was used more commonly in the retrospective versus prospective cohort, admission to hospice within 3 days of death was similar in both cohorts (28.8% v 26.4%), as was the rate of death in an acute care hospital. Retrospective and prospective measures identified similar physician and hospital patterns of end-of-life care. In multivariate models, a visit with an oncologist was positively associated with the use of chemotherapy, opiates, and hospice. Patients who were cared for by oncologists in small group practices were more likely to receive chemotherapy (retrospective only) and less likely to receive hospice (both) than those in large groups. Compared with patients who were cared for in teaching hospitals, those in other hospitals were more likely to receive chemotherapy (both) and to have toxicity (prospective) but were less likely to receive opiates (both) and hospice (retrospective). Conclusion Retrospective and prospective measures, including a new measure of the use of opiate analgesia, identify some similar physician and hospital patterns of end-of-life care.
    Type of Medium: Online Resource
    ISSN: 0732-183X , 1527-7755
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Clinical Oncology (ASCO)
    Publication Date: 2008
    detail.hit.zdb_id: 2005181-5
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    In: International Quarterly of Community Health Education, SAGE Publications, Vol. 29, No. 3 ( 2009-10), p. 223-240
    Abstract: The objective of this study was to better understand high-risk patients' readiness to engage in bone mineral density (BMD) testing to diagnose osteoporosis. Six hundred thirty-six participants in a randomized control trial for patients at high-risk for osteoporosis were surveyed. BMD screening readiness was measured by a three-item summative index. Multivariable linear regression examined the relationship between patients' scores on the index and constructs of osteoporosis and BMD testing knowledge, concern for developing osteoporosis and self-efficacy to engage in fall prevention behaviors. Participants had a mean age of 79 years, 96% were female and 80% were white. Greater concern for developing osteoporosis and better knowledge about BMD testing were significant predictors of a higher score on the index. Improving high-risk patients' knowledge about osteoporosis and the importance of BMD testing may enhance patients' readiness to undergo BMD testing. We found several correlates of readiness to undergo BMD screening that may be used to design effective interventions.
    Type of Medium: Online Resource
    ISSN: 0272-684X , 1541-3519
    Language: English
    Publisher: SAGE Publications
    Publication Date: 2009
    detail.hit.zdb_id: 2071491-9
    detail.hit.zdb_id: 3128673-2
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    Wiley ; 2011
    In:  Journal of the American Geriatrics Society Vol. 59, No. 10 ( 2011-10), p. 1922-1933
    In: Journal of the American Geriatrics Society, Wiley, Vol. 59, No. 10 ( 2011-10), p. 1922-1933
    Abstract: OBJECTIVES: To evaluate the literature regarding the effect of Medicare Part D on the under‐ and overuse of specific medications and corresponding health outcomes. DESIGN: Systematic review. SETTING: Medline search of the peer‐reviewed literature from January 1, 2006, to October 8, 2010. PARTICIPANTS: Medicare beneficiaries who obtained drug insurance from the Part D program. MEASUREMENTS: The review evaluated changes in the use of specific drugs or drug classes after implementation of Part D, as described in original, peer‐reviewed articles. RESULTS: Nineteen articles met inclusion criteria. Part D's implementation was associated with greater use of essential medications such as clopidogrel and statins, especially in beneficiaries who had been previously uninsured, but increases in inappropriate antibiotic use for the treatment of acute respiratory tract infections and increases in claims for the often overused proton pump inhibitor drug class were also observed. In the Part D transition period, dually eligible beneficiaries' drug use remained largely unchanged. When beneficiary cost sharing increased in the coverage gap, use of essential and overused medications declined. CONCLUSION: Increasing drug coverage led to greater use of underused essential medications and inappropriate, or overused, medications under Medicare Part D. Despite efforts to have it do so, the Part D benefit did not sufficiently discriminate between essential and nonessential medication use.
    Type of Medium: Online Resource
    ISSN: 0002-8614 , 1532-5415
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2011
    detail.hit.zdb_id: 2040494-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    Wiley ; 2012
    In:  Journal of the American Geriatrics Society Vol. 60, No. 8 ( 2012-08), p. 1408-1417
    In: Journal of the American Geriatrics Society, Wiley, Vol. 60, No. 8 ( 2012-08), p. 1408-1417
    Abstract: To determine whether Part D coverage gap entry is associated with risk of death or hospitalization for cardiovascular outcomes. Design Prospective cohort study. Beneficiaries entered the study upon reaching the coverage gap spending threshold and were observed until an outcome reaching the threshold for catastrophic coverage occurred or year's end. Nine thousand four hundred thirty‐six exposed individuals (those who were responsible for drug costs in the gap) were compared with 9,436 unexposed individuals (those who received financial assistance) based on propensity score ( PS ) or high‐dimensional propensity score (hd PS ). Setting Medicare Part D drug insurance. Participants Three hundred three thousand nine hundred seventy‐eight Medicare beneficiaries aged 65 and older in 2006 and 2007 with linked prescription and medical claims who enrolled in stand‐alone Part D or retiree drug plans and reached the gap spending threshold. Measurements Rates of death and hospitalization for any of five cardiovascular outcomes, including acute coronary syndrome with revascularization ( ACS ), after reaching the coverage gap spending threshold were compared using Cox proportional hazards models. Results In PS ‐matched analyses, exposed beneficiaries had higher, albeit not significantly so, hazard of death (hazard ratio ( HR ) = 1.25, 95% confidence interval ( CI ) = 0.98–1.59) and ACS ( HR  = 1.16, 95% CI  = 0.83–1.62) than unexposed beneficiaries. hd PS ‐matched analyses minimized residual confounding and confirmed results (death: HR  = 0.99, 95% CI  = 0.78–1.24; ACS : HR = 1.07, 95% CI  = 0.81–1.41). Exposed beneficiaries were no more or less likely to experience other outcomes than were those who were unexposed. Conclusion During the short‐term coverage gap period, having no financial assistance to pay for drugs was not associated with greater risk of death or hospitalization for cardiovascular causes, although long‐term health consequences remain unclear.
    Type of Medium: Online Resource
    ISSN: 0002-8614 , 1532-5415
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2012
    detail.hit.zdb_id: 2040494-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    In: Journal of Bone and Mineral Research, Wiley, Vol. 31, No. 8 ( 2016-08), p. 1536-1540
    Abstract: The U.S. Food and Drug Administration (FDA) issued several announcements related to potential risk of bisphosphonates including osteonecrosis of the jaw (2005), atrial fibrillation (2007), and atypical femur fracture (2010). We aimed to evaluate the impact of three FDA drug safety announcements on the use of bisphosphonates in patients with hip fracture using claims data from a U.S. commercial health plan (2004‐2013). We calculated the proportion of patients in each quarter who received a bisphosphonate or other osteoporosis medication in the 6 months following hospitalization for hip fracture. Segmented logistic regression models examined the time trends. Among 22,598 patients with hip fracture, use of bisphosphonate decreased from 15% in 2004 to 3% in the last quarter of 2013. Prior to the 2007 announcement, there was a 4% increase in the odds of bisphosphonate use every quarter (OR 1.04; 95% CI, 1.02 to 1.07). After the 2007 announcement, there was a 4% decrease in the odds of bisphosphonate use (OR 0.96; 95% CI, 0.93 to 0.99) every quarter. The announcement in 2007 was associated with a significant decline in the rate of change of bisphosphonate uses over time ( p   〈  0.001), but no impact on other osteoporosis medication use ( p  = 0.2). After the 2010 announcement, the odds of bisphosphonate use continued to decrease by 4% (OR 0.96; 95% CI, 0.94 to 0.98) each quarter and the odds of other osteoporosis medication use remained stable over time (OR 0.99; 95% CI, 0.96 to 1.02). The FDA safety announcement related to atrial fibrillation in 2007 was significantly associated with a decrease in bisphosphonate use among patients with hip fracture. © 2016 American Society for Bone and Mineral Research.
    Type of Medium: Online Resource
    ISSN: 0884-0431 , 1523-4681
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2016
    detail.hit.zdb_id: 2008867-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    In: Journal of Bone and Mineral Research, Wiley, Vol. 22, No. 11 ( 2007-11), p. 1808-1815
    Abstract: We conducted a randomized controlled trial within the setting of a large drug benefit plan for Medicare beneficiaries. Primary care physicians and their patients were randomized to usual care, patient intervention only, physician intervention only, or both interventions. There was no difference in the probability of the primary composite endpoint (BMD test or osteoporosis medication) or in either of its components comparing the combined intervention group with usual care (risk ratio = 1.04; 95% CI, 0.85–1.26). Introduction: Fractures from osteoporosis are associated with substantial morbidity, mortality, and cost. However, only a minority of at‐risk older adults receives screening and/or treatment for this condition. We evaluated the effect of educational interventions for osteoporosis targeting at‐risk patients, primary care physicians, or both. Materials and Methods: We conducted a randomized controlled trial within the setting of a large drug benefit plan for Medicare beneficiaries. Primary care physicians and their patients were randomized to usual care, patient intervention only, physician intervention only, or both interventions. The at‐risk patients were women ≥65 yr of age, men and women ≥65 yr of age with a prior fracture, and men and women ≥65 yr of age who used oral glucocorticoids. The primary outcome studied was a composite of either undergoing a BMD test or initiating a medication used for osteoporosis. The secondary outcome was a hip, humerus, spine, or wrist fracture. Results: We randomized 828 primary care physicians and their 13,455 eligible at‐risk patients into four study arms. Physician and patient characteristics were very similar across all four groups. Across all four groups, the rate of the composite outcome was 10.3 per 100 person‐years and did not differ between the usual care and the combined intervention groups ( p = 0.5). In adjusted Cox proportional hazards models, there was no difference in the probability of the primary composite endpoint comparing the combined intervention group with usual care (risk ratio = 1.04; 95% CI, 0.85–1.26). There was also no difference in either of the components of the composite endpoint. The probability of fracture during follow‐up was 4.2 per 100 person‐years and did not differ by treatment assignment ( p = 0.9). Conclusions: In this trial, a relatively brief program of patient and/or physician education did not work to improve the management of osteoporosis. More intensive efforts should be considered for future quality improvement programs for osteoporosis.
    Type of Medium: Online Resource
    ISSN: 0884-0431 , 1523-4681
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2007
    detail.hit.zdb_id: 2008867-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    In: Arthritis Care & Research, Wiley, Vol. 66, No. 11 ( 2014-11), p. 1634-1643
    Abstract: Disease‐modifying antirheumatic drugs (DMARDs) are recommended for all patients with rheumatoid arthritis (RA). Some estimate that approximately one‐half of patients with RA do not receive DMARDs. We hypothesized that patients with RA living farther from rheumatologists would be less likely to receive RA diagnoses and to receive DMARDs. Methods US‐based Medicare patients ages 〉 65 years were study eligible. We calculated driving distance from patients' homes to the nearest rheumatologist. Using multivariable logistic regression, we assessed relationships between driving distance and RA diagnosis and between driving distance and DMARD receipt. In one set of analyses, distance was divided into quartiles: 0–2, 2.1–5, 5.1–15.9, and ≥16 miles. In a second set of analyses, we used predefined categories: 0–15, 15.1–30, 30.1–60, and 〉 60 miles. Results Among 59,426 Medicare beneficiaries, 918 had diagnosed RA. Compared to the first quartile, increased distance was associated with decreased odds of RA diagnosis (odds ratio [OR] 0.96 [95% confidence interval (95% CI) 0.80–1.16] in second quartile, OR 0.88 [95% CI 0.72–1.07] in third quartile, and OR 0.72 [95% CI 0.56–0.93] in fourth quartile; P 〈 0.01 for trend). Similar results were observed using predefined categories. Among those with RA, increased distance was associated with increased odds of DMARD receipt across quartiles (OR 1.15 [95% CI 1.06–1.25] in second quartile, OR 1.41 [95% CI 1.29–1.54] in third quartile, and OR 1.32 [95% CI 1.18–1.46] in fourth quartile; P = 0.001 for trend). There was no relationship between predefined categories and DMARD receipt ( P = 0.45 for trend). Conclusion Increased driving distance to rheumatologists was associated with decreased odds of RA diagnosis. Among those with diagnosed RA, the odds of DMARD receipt rose as distance increased from 〈 2 to 16 miles, but not beyond. Urban residents living closer to rheumatologists may have barriers to DMARD use besides geographic access.
    Type of Medium: Online Resource
    ISSN: 2151-464X , 2151-4658
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2014
    detail.hit.zdb_id: 2016713-1
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    In: Health Affairs, Health Affairs (Project Hope), Vol. 35, No. 7 ( 2016-07), p. 1222-1229
    Type of Medium: Online Resource
    ISSN: 0278-2715 , 1544-5208
    Language: English
    Publisher: Health Affairs (Project Hope)
    Publication Date: 2016
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    Online Resource
    Online Resource
    Elsevier BV ; 2014
    In:  Computational Statistics & Data Analysis Vol. 72 ( 2014-04), p. 219-226
    In: Computational Statistics & Data Analysis, Elsevier BV, Vol. 72 ( 2014-04), p. 219-226
    Type of Medium: Online Resource
    ISSN: 0167-9473
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2014
    detail.hit.zdb_id: 1478763-5
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    Online Resource
    Online Resource
    Elsevier BV ; 2018
    In:  Healthcare Vol. 6, No. 3 ( 2018-09), p. 162-167
    In: Healthcare, Elsevier BV, Vol. 6, No. 3 ( 2018-09), p. 162-167
    Type of Medium: Online Resource
    ISSN: 2213-0764
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2018
    detail.hit.zdb_id: 2724773-9
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages